发明名称 Methods of using SNS-595 for treatment of cancer subjects with reduced BRCA2 activity
摘要 <p>Methods of using SNS-595 for treatment of a subject having cancer with BRCA2 mutation are described. In certain embodiments, the methods comprise administering a therapeutically effective amount of SNS-595 to a subject in need thereof.</p>
申请公布号 AU2010217796(A1) 申请公布日期 2011.09.15
申请号 AU20100217796 申请日期 2010.03.01
申请人 SUNESIS PHARMACEUTICALS, INC. 发明人 HAWTIN, RACHAEL E.;FOX, JUDITH A.
分类号 A61K31/045;A61K31/4375;A61K45/06;A61P35/00 主分类号 A61K31/045
代理机构 代理人
主权项
地址